[Source: Research & Innovation] The weakened immune system in people with HIV/AIDS makes them particularly vulnerable to fungal infections such as cryptococcal meningitis, which can be deadly. The medicine used to treat the condition is flucytosine, and EU-funded researchers have developed a new and more efficient way of producing it. This will cut production costs, making it more affordable for people in low-income countries.
from EUROPA - Syndicated Research News Feed http://ift.tt/2pC1buV
via IFTTT
No comments:
Post a Comment